Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Date: 12/15/2025 1. Introduction Tilray Brands, Inc. (NASDAQ: TLRY) is a diversified global lifestyle consumer packaged goods (CPG) company operating at the dynamic intersection of the cannabis, alcoholic beverage, and wellness industries. Headquartered in New York City, Tilray boasts a significant operational footprint across Canada, the United States, Europe, Australia, New Zealand, and Latin America, [...]
The cannabis sector is experiencing a historic "Santa Claus rally" this December, with stock prices surging across the board following a transformative shift in federal policy. Today, December 19, 2025, markets are still reeling from yesterday’s decisive executive action aimed at ending the federal gridlock that has plagued the
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 9% in the afternoon session after the company's stock fell in a 'buy the rumor, sell the news' reaction as the U.S. government moved to reschedule cannabis.
Christmas has gotten more expensive this year due to inflation and tariffs. Americans of all stripes can use a break. These six unusually active put options from Thursday trading could boost your wallet the day after Christmas. Ho. Ho. Ho!
In a move that has sent shockwaves through the global financial markets, the cannabis sector is currently navigating a period of unprecedented volatility following a landmark regulatory shift. On December 18, 2025, President Donald Trump signed a historic Executive Order directing the Attorney General to expedite the reclassification of marijuana
The financial markets breathed a collective sigh of relief on December 18, 2025, as a long-awaited inflation report finally provided clarity to an investment community that had been trading in the dark for weeks. The release of the November Consumer Price Index (CPI) data—delayed by a historic 43-day government
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 5.2% in the afternoon session after the stock gave back some of its recent gains, which were fueled by reports that the U.S. administration was considering reclassifying marijuana.
Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.
Monday’s tape felt like markets were pacing in the hallway before a doctor’s appointment: slightly red, slightly tense, and absolutely obsessed with the next data print. Oracle kept sliding on “more AI capex” anxiety, while Tesla ripped higher on Cathie Wood’s megaphone? plus a handful of single-stock soap operas stole the show.
